Denis Nash1, Yingfeng Wu, Batya Elul, David Hoos, Wafaa El Sadr. 1. International Center for AIDS Care and Treatment Programs, Columbia University Mailman School of Public Health, New York, New York, USA. dnash@hunter.cuny.edu
Abstract
OBJECTIVE: In sub-Saharan Africa, many patients initiate antiretroviral therapy (ART) at CD4 cell counts much lower than those recommended in national guidelines. We examined program-level and contextual-level factors associated with low median CD4 cell count at ART initiation in populations initiating ART. DESIGN: Multilevel analysis of aggregate and program-level service delivery data. METHODS: We examined data on 1690 cohorts of patients initiating ART during 2004-2008 in eight sub-Saharan African countries. Cohorts with median CD4 less than 111 cells/μl (the lowest quartile) were classified as having low median CD4 cell count at ART initiation. Cohort information was combined with time-updated program-level data and subnational contextual-level data, and analyzed using multilevel models. RESULTS: The 1690 cohorts had median CD4 cell count of 136 cells/μl and included 121,504 patients initiating ART at 267 clinics. Program-level factors associated with low cohort median CD4 cell count included urban setting [adjusted odds ratio (AOR) 2.1; 95% confidence interval (CI) 1.3-3.3], lower provider-to-patient ratio (AOR 2.2; 95% CI 1.3-4.0), no PMTCT program (AOR 3.6; 95% CI 1.0-12.8), outreach services for ART patients only vs. both pre-ART and ART patients (AOR 2.4; 95% CI 1.5-3.9), fewer vs. more adherence support services (AOR 1.6; 95% CI 1.0-2.5), and smaller cohort size (AOR 2.5; 95% CI 1.4-4.5). Contextual-level factors associated with low cohort median CD4 cell count included initiating ART in areas where a lower proportion of the population heard of AIDS, tested for HIV recently, and a higher proportion believed 'limiting themselves to one HIV-uninfected sexual partner reduces HIV risk'. CONCLUSION: Determinants of CD4 cell count at ART initiation in populations initiating ART operate at multiple levels. Structural interventions targeting points upstream from ART initiation along the continuum from infection to diagnosis to care engagement are needed.
OBJECTIVE: In sub-Saharan Africa, many patients initiate antiretroviral therapy (ART) at CD4 cell counts much lower than those recommended in national guidelines. We examined program-level and contextual-level factors associated with low median CD4 cell count at ART initiation in populations initiating ART. DESIGN: Multilevel analysis of aggregate and program-level service delivery data. METHODS: We examined data on 1690 cohorts of patients initiating ART during 2004-2008 in eight sub-Saharan African countries. Cohorts with median CD4 less than 111 cells/μl (the lowest quartile) were classified as having low median CD4 cell count at ART initiation. Cohort information was combined with time-updated program-level data and subnational contextual-level data, and analyzed using multilevel models. RESULTS: The 1690 cohorts had median CD4 cell count of 136 cells/μl and included 121,504 patients initiating ART at 267 clinics. Program-level factors associated with low cohort median CD4 cell count included urban setting [adjusted odds ratio (AOR) 2.1; 95% confidence interval (CI) 1.3-3.3], lower provider-to-patient ratio (AOR 2.2; 95% CI 1.3-4.0), no PMTCT program (AOR 3.6; 95% CI 1.0-12.8), outreach services for ARTpatients only vs. both pre-ART and ARTpatients (AOR 2.4; 95% CI 1.5-3.9), fewer vs. more adherence support services (AOR 1.6; 95% CI 1.0-2.5), and smaller cohort size (AOR 2.5; 95% CI 1.4-4.5). Contextual-level factors associated with low cohort median CD4 cell count included initiating ART in areas where a lower proportion of the population heard of AIDS, tested for HIV recently, and a higher proportion believed 'limiting themselves to one HIV-uninfected sexual partner reduces HIV risk'. CONCLUSION: Determinants of CD4 cell count at ART initiation in populations initiating ART operate at multiple levels. Structural interventions targeting points upstream from ART initiation along the continuum from infection to diagnosis to care engagement are needed.
Authors: Charles Kabugo; Sylver Bahendeka; Raymond Mwebaze; Samuel Malamba; David Katuntu; Robert Downing; Jonathan Mermin; Paul J Weidle Journal: J Acquir Immune Defic Syndr Date: 2005-04-15 Impact factor: 3.731
Authors: Jeffrey S A Stringer; Isaac Zulu; Jens Levy; Elizabeth M Stringer; Albert Mwango; Benjamin H Chi; Vilepe Mtonga; Stewart Reid; Ronald A Cantrell; Marc Bulterys; Michael S Saag; Richard G Marlink; Alwyn Mwinga; Tedd V Ellerbrock; Moses Sinkala Journal: JAMA Date: 2006-08-16 Impact factor: 56.272
Authors: Christopher S Krawczyk; Ellen Funkhouser; J Michael Kilby; Richard A Kaslow; Amita K Bey; Sten H Vermund Journal: South Med J Date: 2006-05 Impact factor: 0.954
Authors: Paula Braitstein; Martin W G Brinkhof; François Dabis; Mauro Schechter; Andrew Boulle; Paolo Miotti; Robin Wood; Christian Laurent; Eduardo Sprinz; Catherine Seyler; David R Bangsberg; Eric Balestre; Jonathan A C Sterne; Margaret May; Matthias Egger Journal: Lancet Date: 2006-03-11 Impact factor: 79.321
Authors: Eugene Mutimura; Diane Addison; Kathryn Anastos; Donald Hoover; Jean Claude Dusingize; Ben Karenzie; Isabelle Izimukwiye; Leo Mutesa; Sabin Nsanzimana; Denis Nash Journal: AIDS Date: 2015-01-02 Impact factor: 4.177
Authors: Matthew P Fox; Kate Shearer; Mhairi Maskew; William Macleod; Pappie Majuba; Patrick Macphail; Ian Sanne Journal: AIDS Date: 2012-09-10 Impact factor: 4.177
Authors: Jonathan M Ellen; Lauren Greenberg; Nancy Willard; James Korelitz; Bill G Kapogiannis; Dina Monte; Cherrie B Boyer; Gary W Harper; Lisa M Henry-Reid; Lawrence B Friedman; René Gonin Journal: JAMA Pediatr Date: 2015-03 Impact factor: 16.193
Authors: Zunyou Wu; Zhenzhu Tang; Yurong Mao; Paul Van Veldhuisen; Walter Ling; David Liu; Zhiyong Shen; Roger Detels; Guanghua Lan; Lynda Erinoff; Robert Lindblad; Diane Gu; Houlin Tang; Lian Hu; Qiuying Zhu; Li Lu; Neal Oden; Albert L Hasson; Yan Zhao; Jennifer M McGoogan; Xianmin Ge; Nanci Zhang; Keming Rou; Jinhui Zhu; Hui Wei; Cynthia X Shi; Xia Jin; Jian Li; Julio S G Montaner Journal: Lancet HIV Date: 2017-08-31 Impact factor: 12.767
Authors: Lincoln Pac; Mara Murray Horwitz; Anne Marion Namutebi; Brandon J Auerbach; Aggrey Semeere; Teddy Namulema; Miriam Schwarz; Robert Bbosa; Allan Muruta; David B Meya; Yukari C Manabe Journal: J Acquir Immune Defic Syndr Date: 2015-04-15 Impact factor: 3.731